Literature DB >> 22885687

Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).

Rengasamy Asokan1, Nirmal K Banda, Gerda Szakonyi, Xiaojiang S Chen, V Michael Holers.   

Abstract

Human CR2 is a B cell membrane glycoprotein that plays a central role in autoimmunity. Systemic lupus erythematosus (SLE) patients show reduced CR2 levels, and complete deficiency of CR2 and CR1 promotes the development of anti-DNA antibodies in mouse models of SLE. Here we show that multiple forms of DNA, including bacterial, viral and mammalian DNA, bind to human CR2 with moderately high affinity. Surface plasmon resonance studies showed that methylated DNA bound with high affinity with CR2 at a maximal K(D) of 6nM. DNA was bound to the first two domains of CR2 and this binding was blocked by using a specific inhibitory anti-CR2 mAb. DNA immunization in Cr2(-/-) mice revealed a specific defect in immune responses to bacterial DNA. CR2 can act as a receptor for DNA in the absence of complement C3 fixation to this ligand. These results suggest that CR2 plays a role in the recognition of foreign DNA during host-immune responses. This recognition function of CR2 may be a mechanism that influences the development of autoimmunity to DNA in SLE.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885687      PMCID: PMC3439536          DOI: 10.1016/j.molimm.2012.07.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  57 in total

Review 1.  Toll-like receptors in health and disease: complex questions remain.

Authors:  Ian Sabroe; Robert C Read; Moira K B Whyte; David H Dockrell; Stefanie N Vogel; Steven K Dower
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

Review 2.  The complement system in regulation of adaptive immunity.

Authors:  Michael C Carroll
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 3.  Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).

Authors:  J M Ahearn; D T Fearon
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

4.  Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.

Authors:  J J Weis; S A Richards; J A Smith; D T Fearon
Journal:  J Immunol Methods       Date:  1986-08-21       Impact factor: 2.303

5.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Authors:  J D Fingeroth; J J Weis; T F Tedder; J L Strominger; P A Biro; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.

Authors:  R H Carter; M O Spycher; Y C Ng; R Hoffman; D T Fearon
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

7.  The use of fluorometric assays to assess the immune response to DNA in murine systemic lupus erythematosus.

Authors:  L Björkman; C F Reich; D S Pisetsky
Journal:  Scand J Immunol       Date:  2003-06       Impact factor: 3.487

8.  CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE.

Authors:  Susan A Boackle; Kristin K Culhane; Jared M Brown; Mark Haas; Lihua Bao; Richard J Quigg; V Michael Holers
Journal:  Autoimmunity       Date:  2004-03       Impact factor: 2.815

9.  Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions.

Authors:  J P Portanova; R E Arndt; E M Tan; B L Kotzin
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

10.  Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.

Authors:  K Iida; L Nadler; V Nussenzweig
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  11 in total

1.  Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Authors:  Mariann Kremlitzka; Bernadett Mácsik-Valent; Anna Erdei
Journal:  Cell Mol Life Sci       Date:  2014-12-28       Impact factor: 9.261

2.  Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection.

Authors:  R Herrero; L M Real; A Rivero-Juárez; J A Pineda; Á Camacho; J Macías; M Laplana; P Konieczny; F J Márquez; J C Souto; J M Soria; I Saulle; S Lo Caputo; M Biasin; A Rivero; J Fibla; A Caruz
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

3.  Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.

Authors:  Vincent Gies; Jean-Nicolas Schickel; Sophie Jung; Aurélie Joublin; Salomé Glauzy; Anne-Marie Knapp; Anne Soley; Vincent Poindron; Aurélien Guffroy; Jin-Young Choi; Jacques-Eric Gottenberg; Jennifer H Anolik; Thierry Martin; Pauline Soulas-Sprauel; Eric Meffre; Anne-Sophie Korganow
Journal:  JCI Insight       Date:  2018-03-08

4.  CD38, CD81 and BAFFR combined expression by transitional B cells distinguishes active from inactive systemic lupus erythematosus.

Authors:  Ana Henriques; Isabel Silva; Luís Inês; M Margarida Souto-Carneiro; M Luísa Pais; Hélder Trindade; José António Pereira da Silva; Artur Paiva
Journal:  Clin Exp Med       Date:  2015-04-18       Impact factor: 3.984

5.  TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage.

Authors:  Emily Archer Slone; Michael R Pope; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Am J Clin Exp Immunol       Date:  2012

Review 6.  Genetics and epigenetics of systemic lupus erythematosus.

Authors:  Patrícia Costa-Reis; Kathleen E Sullivan
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

7.  Immune Tolerance to Apoptotic Self Is Mediated Primarily by Regulatory B1a Cells.

Authors:  Katherine Miles; Joanne Simpson; Sheila Brown; Graeme Cowan; David Gray; Mohini Gray
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

Review 8.  Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis.

Authors:  Sofie Vandendriessche; Seppe Cambier; Paul Proost; Pedro E Marques
Journal:  Front Cell Dev Biol       Date:  2021-02-11

9.  Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells.

Authors:  Kristóf G Kovács; Bernadett Mácsik-Valent; János Matkó; Zsuzsa Bajtay; Anna Erdei
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

10.  Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching.

Authors:  Melinda Herbáth; Krisztián Papp; Anna Erdei; József Prechl
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.